Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes

This publication has 8 references indexed in Scilit:

• Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease?
  Published by Elsevier ,2004
• American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Emergency Physicians, American Heart Association, Cardiac Society of Australia & New Zealand, National Heart Foundation of Australia, Society for Cardiac Angiography and Interventions, and the Taiwan Society of Cardiology
  Journal of the American College of Cardiology, 2001
• Nerve growth factor and brain-derived neurotrophic factor mRNAs are regulated in distinct cell populations of rat heart after ischaemia and reperfusion
  The Journal of Pathology, 2001
• NGF, BDNF, Leptin, and Mast Cells in Human Coronary Atherosclerosis and Metabolic Syndrome
  Archives of Physiology and Biochemistry, 2001
• Nerve Growth Factor in Neurological and Non-Neurological Diseases: Basic Findings and Emerging Pharmacological Prospectives
  Current Pharmaceutical Design, 2001
• Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization
  Development, 2000
• Reduced Myocardial Nerve Growth Factor Expression in Human and Experimental Heart Failure
  Circulation Research, 2000
• Protective Role of Nerve Growth Factor Against Postischemic Dysfunction of Sympathetic Coronary Innervation
  Circulation, 1997